Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
OBESITY SURGERY, cilt.28, sa.11, ss.3415-3423, 2018 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 28 Sayı: 11
- Basım Tarihi: 2018
- Doi Numarası: 10.1007/s11695-018-3346-1
- Dergi Adı: OBESITY SURGERY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.3415-3423
- Anahtar Kelimeler: Obesity, Bariatric surgery, Roux-en-Y gastric bypass, Diabetes mellitus, RANDOMIZED CLINICAL-TRIAL, OBESITY-RELATED COMORBIDITIES, TYPE-2 DIABETES-MELLITUS, ALL-CAUSE MORTALITY, 5-YEAR FOLLOW-UP, BODY-MASS INDEX, BARIATRIC SURGERY, MORBID-OBESITY, CARDIOVASCULAR-DISEASE, MEDICAL THERAPY
- İstanbul Üniversitesi Adresli: Hayır
Özet
Sleeve gastrectomy (LSG) is now the predominant bariatric surgery performed, yet there is limited long-term data comparing important outcomes between LSG and Roux-en-Y gastric bypass (RYGB). This study compares weight loss and impact on comorbidities of the two procedures.